Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | MVD | P53602 | 1/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL28481504 | 1.00 | FDPS (0.50) | FDPSBLMTDP1LPAR3LPAR1 | |
| SCHEMBL28788113 | 0.89 | MVD (0.40) | FDPSBLMTDP1LPAR3LPAR1 | |
| Pyrophosphoric Acid SCHEMBL73401 | 0.86 | MMP1 (0.47) | FDPSBLMTDP1LPAR3LPAR1 | |
| Pyrophosphoric Acid SCHEMBL73402 | 0.86 | MMP1 (0.47) | FDPSBLMTDP1LPAR3LPAR1 | |
| Pyrophosphoric Acid SCHEMBL490709 | 0.86 | MMP1 (0.47) | FDPSBLMTDP1LPAR3LPAR1 | |
| Pyrophosphoric Acid SCHEMBL288516 | 0.86 | MMP1 (0.47) | FDPSBLMTDP1LPAR3LPAR1 | |
| Pyrophosphoric Acid SCHEMBL28344128 | 0.84 | LPAR3 (0.47) | FDPSBLMTDP1LPAR3LPAR1 | |
| Phosphoric Acid SCHEMBL2683526 | 0.84 | FDPS (0.50) | FDPSLPAR3LPAR2CA12CA2 | |
| Phosphoric Acid SCHEMBL5874368 | 0.84 | FDPS (0.50) | FDPSLPAR3LPAR2CA12CA2 | |
| Pyrophosphoric Acid SCHEMBL9547118 | 0.82 | LPAR3 (0.50) | FDPSBLMTDP1LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9035041-B2 | Process for triphosphate oligonucleotide synthesis | ALNYLAM PHARMACEUTICALS, INC. (US) | 2015-05-19 | — | — | US | disclosed |
| US-20120220761-A1 | PROCESS FOR TRIPHOSPHATE OLIGONUCLEOTIDE SYNTHESIS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2012-08-30 | — | — | US | disclosed |
| US-20110282044-A1 | PROCESS FOR SYNTHESIZING OLIGONUCLEOTIDE PHOSPHATE DERIVATIVES | ALNYLAM PHARMACEUTICALS (US) | 2011-11-17 | — | — | US | disclosed |
| WO-2011028218-A1 | PROCESS FOR TRIPHOSPHATE OLIGONUCLEOTIDE SYNTHESIS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2011-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220761-A1 | PROCESS FOR TRIPHOSPHATE OLIGONUCLEOTIDE SYNTHESIS | DUT, DTYMK, ITPA | FDPS 43/4885BLM 1145/4885TDP1 337/4885 |
| US-20110282044-A1 | PROCESS FOR SYNTHESIZING OLIGONUCLEOTIDE PHOSPHATE DERIVATIVES | PPA1, TYMP, DCTPP1 | FDPS 44/4885BLM 1471/4885TDP1 424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.